Toshiba 2011 Annual Report Download - page 33

Demand for new construction remained slow
in Japan in FY2010 but stable demand overseas,
particularly in China, allowed us to secure higher
net sales. We maintained operating income at
almost the same level as in the year earlier period.
In Japan we took proactive steps in the high
growth renewal market by introducing products
with added safety and anti-earthquake features.
Overseas, we focused on China and Southeast Asia.
In China, we won an order for 22 elevators and 19
escalators for the Hongqiao Development Zone’s
“L’Avenue Shanghai” in Shanghai, plus orders for 21
elevators, including high speed elevators for
“Shenzhen Kerry Plaza Phase II,” in Shenzhen.
Drawing on over
130 years of developing
world-class technology
standards, we will
continue to provide safe,
comfortable moving
spaces.
An artist’s impression of Avenue
Shanghai, which we will supply with 22
elevators and 19 escalators. Scheduled
for starting operation in January 2012
From planning and consultation to application
and maintenance, our know-how in IT provides
clients in many industries with total solutions to
increasingly complex management issues.
In Japan, economic slowdown and stagnant
corporate results in FY2010 held back recovery in
IT investment in many areas. As the business
environment remained severe, measures including
cuts in fixed costs allows us to overcome lower net
sales and to increase operating profit.
In future, we will provide customers with
services, including “cloud integration,” that suit
their business environments and meet their needs.
We will establish a basis for cloud-based business,
a market expected to enjoy considerable growth.
We deliver health care solutions on a global basis,
including medical IT systems and diagnostic
imaging equipment, such as CT, MRI, ultrasound
and X-ray systems.
In FY2010, continued rapid growth in the
Chinese market resulted in good sales in CT
systems. However, a slowdown in the wider global
market and stronger price competition due to the
strong yen brought down sales and operating
income.
In the United States, we were able to increase
orders for X-ray angiography systems and other
products. In Japan, we supplied a large-bore CT
system for the new treatment room for heavy-ion
cancer therapy at the National Institute of
Radiological Sciences, which Toshiba Corporation
provided with a next generation irradiation system
for heavy-ion cancer therapy. The CT secures the
pinpoint location determination essential for
effective treatment.
In future, we will improve growth by
strengthening our presence in emerging markets
and new businesses. Our tri-polar research and
development structure, based in Japan, the United
States and Europe, will support us in contributing
to global advances in medicine by providing the
high quality, highly reliability medical systems and
services.
Toshiba Solutions Corporation
Toshiba Medical Systems Corporation
Next generation irradiation system (right) and large-bore CT (left) in the new treatment room
for heavy-ion cancer therapy at the National Institute of Radiological Sciences
TOSHIBA Annual Report 2011
A01_東芝様AR2011_前半.indd 31 11.8.15 5:14:52 PM